| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $36.5M | +52.3% |
| SG&A Expense | $22.4M | +11.9% |
| Operating Income | -$58.9M | -33.9% |
| Pre-tax Income | -$45.5M | -47.5% |
| Net Income | -$45.5M | -47.5% |
| EPS (Basic) | $1.09 | +39.7% |
| EPS (Diluted) | $1.09 | +39.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $285.1M | +5.9% |
| Current Assets | $290.5M | +6.6% |
| Total Assets | $294.6M | +6.1% |
| Current Liabilities | $7.1M | +31.2% |
| Total Liabilities | $9.5M | +9.6% |
| Stockholders' Equity | $285.1M | +6.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.5M | -68.9% |
| Capital Expenditures | $10K | -94.1% |
| Investing Cash Flow | -$10K | +94.1% |
| Financing Cash Flow | $50.5M | +6221.2% |
| Free Cash Flow | -$34.5M | -67.6% |